Newborn Resistance

Exploring the low rate of HCV infection in newborns

Unlike other blood-borne viruses such as HIV and hepatitis B, the risk of a baby being infected with hepatitis C during the mother’s pregnancy or during birth is very low. Only about 5% of babies born to mothers who have hepatitis C are themselves infected by the disease. A possible reason for this low figure is that the baby’s immune system has already destroyed the virus
before birth. A new study from researchers at Sweden’s Karolinska Institutet, published in the journal Gut, reveals clear adaptations of the uninfected babies’ immune system that may now lead the way to new treatment methods.

Cartoon image of mother breastfeeding newborn baby

“The immune system of the [exposed but non-infected] babies shows similar changes to that in babies infected with hepatitis C,” explained Niklas Björkström, a doctor and researcher at the Institutet. “This could suggest that the immune cells have encountered the virus in the womb and managed to eliminate it before birth.”

The study was conducted in collaboration with a maternity hospital in Saint Petersburg, Russia. Of the 55 pregnant women participating, 40 had an active hepatitis C infection, while the others had been cured, but still tested positive for hepatitis C antibodies. 

The babies born to women with an active infection were all considered exposed to the virus; despite this, only three of these 40 babies developed hepatitis C.

All the infants were monitored up to the age of 18 months through regular testing, and to increase the volume of comparable data, samples were added from 18 infants who had been infected with hepatitis C at birth.

This is particularly important research in the quest for a vaccine for hepatitis C.

The study showed that both the babies born with an infection and the babies who had been exposed to the virus by an infected mother had similar changes in their adaptive immune system, with clear adaptations of the body’s B lymphocytes, the role of which is to produce antibodies able to discover and identify alien microbes, such as viruses, bacteria and parasites.

“A possible explanation is that most babies exposed to the virus in utero manage to deal with it, which we can later see by the B lymphocytes,” said Dr Björkström. “One interesting hypothesis is that these cells can contain novel information that we can use to protect ourselves against hepatises C in the future.”

Cartoon image of swaddled newborn with dummy

This is particularly important in the quest for a vaccine for hepatitis C. “This is why we need to continue researching,” Dr Björkström said. “We need to understand what it’ll take to obtain lasting protection against the virus. Only then can we attain the WHO goal of elimination.”

The researchers will now be investigating whether other immune cells in the infants have changed in a similar way. You can see the study here.

This article first appeared in issue 86 of the Hepatitis SA Community News.

Five Years of CNP Peers: Part 1

Among its other services, Hepatitis SA runs four Clean Needle Program (CNP) sites in Adelaide, at Hackney, Noarlunga, Port Adelaide, and Salisbury. Our CNP peer educators also attend rostered sessions at other sites at various times during the week.

Continue reading “Five Years of CNP Peers: Part 1”

Coronavirus and Hepatitis

What are the risks of coronavirus COVID-19 for people living with hepatitis B or hepatitis C? People with weakened immune systems (e.g. people on immune suppressing medications, people receiving cancer treatments), older people especially those aged over 70 years, Aboriginal and Torres Strait Islander people and people with chronic medical conditions are particularly at risk from the effects of COVID-19.

Continue reading “Coronavirus and Hepatitis”

Keep Calm and Carry Naloxone

Most accidental overdoses in Australia—especially South Australia—are from prescription drugs, mainly painkillers and sleeping tablets. Many of these deaths can be prevented with a drug that reverses the effects of opioids.

From 1 December 2019 to February 2021, South Australia is taking part in a PBS-subsidised pilot program to reduce opioid-related deaths by making the life-saving medicine, naloxone, available to more people.

Continue reading “Keep Calm and Carry Naloxone”